![PDF) Sinusoidal endothelial cells and vascular endothelial growth factor are key players in an in-vitro model of oxaliplatin-induced sinusoidal obstruction syndrome PDF) Sinusoidal endothelial cells and vascular endothelial growth factor are key players in an in-vitro model of oxaliplatin-induced sinusoidal obstruction syndrome](https://i1.rgstatic.net/publication/328053066_Sinusoidal_endothelial_cells_and_vascular_endothelial_growth_factor_are_key_players_in_an_in-vitro_model_of_oxaliplatin-induced_sinusoidal_obstruction_syndrome/links/5fe31d5e299bf14088378632/largepreview.png)
PDF) Sinusoidal endothelial cells and vascular endothelial growth factor are key players in an in-vitro model of oxaliplatin-induced sinusoidal obstruction syndrome
![JOSEPHINE - Een uitgave van het Erasmus MC Kanker Instituut - ForYou B.V. | Flipboekje Online | FlipHTML5 JOSEPHINE - Een uitgave van het Erasmus MC Kanker Instituut - ForYou B.V. | Flipboekje Online | FlipHTML5](https://online.fliphtml5.com/akpq/otea/files/large/1.jpg?1585579369)
JOSEPHINE - Een uitgave van het Erasmus MC Kanker Instituut - ForYou B.V. | Flipboekje Online | FlipHTML5
![PDF) 1723PMicroRNA expression and DNA methylation profiles do not distinguish between primary and recurrent well-differentiated liposarcoma PDF) 1723PMicroRNA expression and DNA methylation profiles do not distinguish between primary and recurrent well-differentiated liposarcoma](https://i1.rgstatic.net/publication/336193745_1723PMicroRNA_expression_and_DNA_methylation_profiles_do_not_distinguish_between_primary_and_recurrent_well-differentiated_liposarcoma/links/5df7a6824585159aa482c6d8/largepreview.png)
PDF) 1723PMicroRNA expression and DNA methylation profiles do not distinguish between primary and recurrent well-differentiated liposarcoma
Rotterdam van toen - De bouw van de dr. Daniel den Hoed-kliniek aan de Groene Hilledijk, gezien vanaf de Valkeniersweide, 21 mei 1963. Daniël den Hoed (Gouda, 18 oktober 1899 – Rotterdam,
![Eric VAN DER STOK | PhD Candidate, General Surgery Resident | Erasmus MC, Rotterdam | Erasmus MC | Daniel den Hoed Centre | Research profile Eric VAN DER STOK | PhD Candidate, General Surgery Resident | Erasmus MC, Rotterdam | Erasmus MC | Daniel den Hoed Centre | Research profile](https://c5.rgstatic.net/m/437738464651637/images/template/default/profile/profile_default_l.jpg)
Eric VAN DER STOK | PhD Candidate, General Surgery Resident | Erasmus MC, Rotterdam | Erasmus MC | Daniel den Hoed Centre | Research profile
![PDF) Early destruction of tumor vasculature in tumor necrosis factor-??-based isolated limb perfusion is responsible for tumor response PDF) Early destruction of tumor vasculature in tumor necrosis factor-??-based isolated limb perfusion is responsible for tumor response](https://i1.rgstatic.net/publication/6847551_Early_destruction_of_tumor_vasculature_in_tumor_necrosis_factor--based_isolated_limb_perfusion_is_responsible_for_tumor_response/links/5a4cfb63458515a6bc6dace4/largepreview.png)
PDF) Early destruction of tumor vasculature in tumor necrosis factor-??-based isolated limb perfusion is responsible for tumor response
![PDF) Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF--based isolated hepatic perfusion PDF) Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF--based isolated hepatic perfusion](https://i1.rgstatic.net/publication/10878633_Degree_of_tumour_vascularity_correlates_with_drug_accumulation_and_tumour_response_upon_TNF--based_isolated_hepatic_perfusion/links/02bfe50dcb19189e46000000/largepreview.png)
PDF) Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF--based isolated hepatic perfusion
![Lack of efficacy of Doxil® in TNF-α-based isolated limb perfusion in sarcoma-bearing rats | British Journal of Cancer Lack of efficacy of Doxil® in TNF-α-based isolated limb perfusion in sarcoma-bearing rats | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6601688/MediaObjects/41416_2004_Article_BF6601688_Fig1_HTML.gif)